Open-Label Extension Protocol to SNK01-AD01 Study

Clinical trial NCT07228078 · RECRUITING

Trial details

NCT number: NCT07228078
Sponsor: NKGen Biotech, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2025-06-30
Primary completion: 2028-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.